SUPPLEMENTARY FIGURES
. Identification of RPN13 as a 42 kDa cellular target of RA183B (A) Untreated and RA183B-treated (1 µM, 45 min, 4 °C) SKOV3 lysate was incubated overnight with streptavidin-coated magnetic beads. The beads were separated with a magnet, washed and the bound proteins eluted with 10 mM EDTA pH 8.2 and 95% formamide for 10 min at 90 °C. The input lysate (input), supernatant after bead extraction (SN) and eluates from beads Page S12
Figure S6. In Vitro Microsomal Stability of RA183 and RA190
RA183 stability and metabolism studies were conducted in a 0.5M sodium-potassium phosphate buffer (pH 7.4) containing 20 mg/mL of either human or mouse liver microsomes, NADPHgenerating system A and B, and 10 mM of RA183 in a final volume of 500 µL. Negative controls were performed without NADPH-generating system to control for native enzyme activities.
Incubations were performed in duplicate in glass tubes maintained at 37 °C in a shaker bath.
Reactions were terminated immediately or after 0.5 or 1 hr by taking 20 µL of the reaction mixture and adding 1 mL of acetonitrile, followed by vortex-mixing then centrifugation for 10 min at 1430 x g. A 10 µL aliquot of the supernatant was injected onto the UPLC instrument for qualitative analysis using a temperature-controlled autosampling device operating at 5°C.
Figure S7. Metabolite analysis of RA183
Chromatographic analysis was performed using a Waters Acquity TM UItra Performance LC.
Separation of the analyte from potentially interfering material and metabolites was achieved at ambient temperature using Agilent Zorbax XDB C18 column (50 x 2.1 mm i.d.) with a 3.5 µm particle size. (Santa Clara, CA). The mobile phase used for the chromatographic separation was composed of 0.1% (v/v) formic acid in water (mobile phase A) and 0.1% (v/v) formic acid in acetonitrile (mobile phase B) with a flow rate of 0.3 mL/min. The initial mobile phase composition was 80% mobile phase A and 20% mobile phase B. From 0 to 7 min, mobile phase B was increased linearly from 20% to 50%. From 7 to 8 min, mobile phase B was increased linearly from 50% to 100% and maintained until 9 min. From 9.0 to 9.1 min, the gradient decreased to 20% mobile phase B and the conditions were maintained until 12 min to re-equilibrate the column for the next injection. The column effluent was monitored using an AB Sciex QTrap TM 5500. The instrument was equipped with an electrospray interface, operated in a positive mode and controlled by the Analyst v1.6 software. For the stability study, the mass spectrometer was programmed to monitor the following MRM transition 513.1  120.1 for RA183. Results were assessed qualitatively comparing the average area ratio of RA183 at 0hr
to area ratio at 0.5 hr and 1 hr for both mouse and human liver microsomes. While the LC method remained the same, the following mass spectrometer experiments were performed to help determine the metabolites and their structures: full scan, MRM (multiple reaction monitoring), and precursor and neutral loss of various Q3 fragments. Possible metabolites were identified having a signal intensity greater than 3 times the intensity of the control sample. The methods and results were processed using LightSight v2.3 software. 
